These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vasodilators: minoxidil and drugs used in peripheral vascular and cerebral disorders. Lowe GD. Br Med J (Clin Res Ed); 1983 Apr 16; 286(6373):1262-4. PubMed ID: 6404416 [No Abstract] [Full Text] [Related]
3. [On the effect of pyrithioxine on cerebral changes in aging]. Hofmann G, Salvendy JT. Wien Z Nervenheilkd Grenzgeb; 1968 Apr 16; 26(3):279-84. PubMed ID: 4235305 [No Abstract] [Full Text] [Related]
4. [Effects of Pyritinol (Encephabol) in psychiatry]. Wardaszko-Lyskowska H, Zardecka-Mieścicka M. Psychiatr Pol; 1970 Apr 16; 4(2):161-7. PubMed ID: 5427760 [No Abstract] [Full Text] [Related]
5. [The use of nicotinyl alcohol in delayed-action form in some obstetrical gynecological vascular diseases]. De Marini M. Minerva Ginecol; 1969 Jan 31; 21(2):63-6. PubMed ID: 5776754 [No Abstract] [Full Text] [Related]
7. [A delayed-action therapeutic agent in chronic cerebral circulatory insufficiencies]. Boudouresques J, Papy JJ, Daniel F. Therapeutique; 1970 Oct 31; 46(8):789-92. PubMed ID: 5458910 [No Abstract] [Full Text] [Related]
8. [Recent experiences with pyrithioxine in the treatment of various nervous system diseases in children]. Lesný I, Rössler M, Tokalaki L. Cesk Pediatr; 1974 Oct 31; 29(10):562-4. PubMed ID: 4442189 [No Abstract] [Full Text] [Related]
9. Treatment of peripheral arterial insufficiency with inositoli nicotinas (Hexanicit). Hentzer E. Scand J Clin Lab Invest Suppl; 1967 Oct 31; 99():226-32. PubMed ID: 4862834 [No Abstract] [Full Text] [Related]
10. [On the circulatory physiology and biochemistry of cerebral degeneration processes and influencing the behavior of patients with drug therapy]. Cornu F. Wien Klin Wochenschr; 1969 Jun 06; 81(23):426-31. PubMed ID: 5790194 [No Abstract] [Full Text] [Related]
11. Clinical responses to Cinnarizin in various psychiatric syndromes. Szobor A, Klein M. Ther Hung; 1973 Jun 06; 21(1):31-4. PubMed ID: 4792889 [No Abstract] [Full Text] [Related]
12. Psychopharmacological treatment of disorders of senescence. Fann WE, Wheless JC, Richman BW. N C Med J; 1974 Nov 06; 35(11):672-7. PubMed ID: 4530160 [No Abstract] [Full Text] [Related]
13. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases]. Florio F, Ruffolo S, Piro E. Minerva Cardioangiol; 1976 Feb 06; 24(2):161-70. PubMed ID: 1256656 [No Abstract] [Full Text] [Related]
14. [The therapeutic effects of flunarizine in peripheral arterial diseases and cerebrovascular diseases]. De Gregorio G, Restivo S. Clin Ter; 1982 Dec 15; 103(5):501-7. PubMed ID: 7160142 [No Abstract] [Full Text] [Related]
15. [Treatment of cerebral vascular insufficiency syndromes in old age. Controlled research by double blind technic]. Mars G, Nebuloni G. G Gerontol; 1970 Mar 15; 18(3):153-76. PubMed ID: 4919664 [No Abstract] [Full Text] [Related]
16. [On the therapy of cerebral and peripheral circulatory disorders in general practice]. Risse S. Med Welt; 1967 Jul 15; 28():1659-62. PubMed ID: 5612140 [No Abstract] [Full Text] [Related]